Research Activity – Page 27

Roche looks to expand and upgrade US research centers as part of $50B investment strategy in the country

7 months ago talkbio0Tagged Expanding, expansion, Indiana, Investments, Pennsylvania, Research Organization, Roche (company), United States, Upgrade

Roche (company), Indiana, United States, Investments, expansion, Pennsylvania, Expanding, upgrade, Research Organization

Ono Pharmaceutical and Jorna Therapeutics Partner for AI-Driven RNA Editing Therapies

7 months ago talkbio0Tagged Artificial Intelligence, Dosage Forms, Drug Discovery, Jorna, RNA

Ono Pharmaceutical, Jorna Therapeutics, AI Drug Discovery, RNA Editing Therapies

Chinese CRO GemPharmatech expands in San Diego as industry weighs FDA’s animal testing shift

7 months ago talkbio0Tagged Animal Testing, Contract Research Organization, expansion, GemPharmatech, Industry, mouse models, San Diego, United States Food and Drug Administration

United States Food and Drug Administration, GemPharmatech, Contract Research Organization, San Diego, Animal Testing, mouse models, expansion, Industry

Lilly’s oral GLP-1 succeeds in first Phase III test, delivering promising weight loss

7 months ago talkbio0Tagged Diabetes Mellitus, Non-Insulin-Dependent, Glucagon-Like Peptide 1, Hemoglobin A1c measurement, Injectables, Oral cavity, orforglipron, Phase 3 Clinical Trials, Safety, Weight Loss

orforglipron, Glucagon-Like Peptide 1, Weight Loss, Oral cavity, orforglipron, Phase 3 Clinical Trials, Diabetes Mellitus, Non-Insulin-Dependent, Hemoglobin A1c measurement, Safety, Injectables

Sanofi pens $1.8B research deal for 2 bispecific antibodies aimed at autoimmune, immunology

7 months ago talkbio0Tagged Antibodies, Bispecific, Autoimmune, Collaboration, development aspects, Earendil Labs, Immunology, Inflammatory Bowel Diseases, sanofi

Antibodies, Bispecific, Autoimmune, Inflammatory Bowel Diseases, sanofi, Earendil Labs, Immunology, Collaboration, development aspects

HHS Terminates Funding for GeoVax’s Next-Generation COVID-19 Vaccine: Impacts and Developments

7 months ago talkbio0Tagged BARDA, CHARGE Syndrome, Clinical Trials, COVID19 (disease), development aspects, GeoVax, Immunocompromised Host, pandemic preparedness, Project NextGen, Termination - Inactive Reason Code, Vaccines

GeoVax, HHS, BARDA, Project NextGen, COVID-19 vaccine, GEO-CM04S1, clinical trials, funding termination, immunocompromised, vaccine development, pandemic preparedness

Sanofis $1.4B Kymab Bet Falters as Asthma Drug Stumbles in Phase II

7 months ago talkbio0Tagged Amlitelimab, Asthma, Immunology, Kymab, sanofi

Asthma, Amlitelimab, Kymab, sanofi, Immunology

Sanofi tempers its OX40 expectations in asthma after mid-stage miss

7 months ago talkbio0Tagged Amlitelimab, Asthma, exacerbations, Expectations, sanofi, Subgroup A Nepoviruses, TNFRSF4 gene

Asthma, Amlitelimab, TNFRSF4 gene, sanofi, exacerbations, Subgroup A Nepoviruses, Expectations

Bristol Myers says Camzyos fails Phase 3 study in genetic heart condition

7 months ago talkbio0Tagged Camzyos, Clinical Trials, Hypertrophic Cardiomyopathy, Hypertrophic cardiomyopathy without obstruction, Myers, Obstructed

Camzyos, Hypertrophic Cardiomyopathy, Myers, Hypertrophic cardiomyopathy without obstruction, Obstructed, Clinical Trials

Harvard Faces $2.2 Billion Federal Funding Freeze After Defying Trump Administration Demands

7 months ago talkbio0Tagged Academia (organization), Administration occupational activities, antisemitism, battle, campus, civil, DEI, Diversity, federal, Freezing, Harvard University, Legal, protest, Research Projects, R-Series, Status, Transplant Registry Unified Management Program, university governance

Harvard University, Trump administration, federal funding freeze, $2.2 billion, research grants, diversity equity inclusion (DEI), antisemitism, academic independence, campus protests, Title VI, civil rights, university governance, legal battle, tax exempt status